HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Submit a response Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Tamaki, Y. Articles by Tomita, K. Search for Related Content PubMed PubMed Citation Articles by Tamaki, Y. Articles by Tomita, K.

Effects of Lomerizine, a Calcium Channel Antagonist, on Retinal and Optic Nerve Head Circulation in Rabbits and Humans

From the Department of Ophthalmology, University of Tokyo School of Medicine, Tokyo, Japan.

PURPOSE. To investigate the effects of lomerizine, a Ca²⁺ antagonist, on the ocular tissue circulation in rabbits and on the circulation in the optic nerve head (ONH) and choroid in healthy volunteers.

METHODS. Lomerizine (0.1 [n = 10] or 0.3 [n = 11] mg/kg) or vehicle solution (n = 11) was injected intravenously in urethane-anesthetized rabbits, and blood flow in the retina, choroid, and iris-ciliary body was measured by the microsphere method and that in the ONH by the H₂ gas-clearance method (0.1 [n = 6] or 0.3 [n = 9] mg/kg or vehicle, n = 6). Oral 5 mg lomerizine or placebo was administered to volunteers (n = 8) in a crossover study, and in areas of the fovea and ONH, the normalized blur (NB), a quantitative index of blood velocity, was measured, together with blood pressure, heart rate, and intraocular pressure (IOP), before and 1.5, 3, 6, and 9 hours after administration.

RESULTS. Blood flow in the rabbit retina increased significantly in the lomerizine-treated group, but blood flow changed little in the choroid or iris-ciliary body. Blood flow in the rabbit ONH also showed a significant increase in the lomerizine-treated group. In human studies, the NB obtained from the ONH during the experimental period showed a small but significant increase in the lomerizine-treated group compared with the placebo-treated group, but no significant intergroup difference was detected in the NB obtained from the fovea or in blood pressure, heart rate, or IOP.

CONCLUSIONS. Lomerizine increases blood velocity, and probably blood flow, in the ONH and retina in rabbits, and it also increases blood velocity in the ONH in healthy humans, without significantly altering blood pressure or heart rate.

This article has been cited by other articles:

				J. Takayama, A. Tomidokoro, Y. Tamaki, and M. Araie Time Course of Changes in Optic Nerve Head Circulation after Acute Reduction in Intraocular Pressure Invest. Ophthalmol. Vis. Sci., April 1, 2005; 46(4): 1409 - 1419. [Abstract] [Full Text] [PDF]